SILODOSIN 8mg. IP + DUTASTERIDE 0.5mg. IP

An alpha-blocker and 5-alpha-reductase inhibitor are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia in men with an enlarged prostate. Relaxes the muscles in the prostate and the bladder which allows easy passage of urine. Helps in lowering prostate growth by decreasing testosterone levels. Helps lessens benign prostatic hyperplasia symptoms and improves the ability to urinate. An effective and safe treatment for acute urinary retention due to benign prostatic hyperplasia. (Kazuhisa Hagiwara, 2016) Provides rapid and significant relief from benign prostatic hyperplasia-related symptoms. (Steven A Kaplan, 2011) Improves the symptoms of benign prostate hyperplasia with enlarged prostate, especially in comorbid conditions like hypertension, obesity, and dyslipidemia. (Chetan Mehndiratta, 2015) Reduces the risk of a complete blockage of urine flow and prostate surgery. Ameliorates lower urinary tract symptoms, including diurnal voiding, storage symptoms, nocturia, and quality of life.